Astal Laboratories Limited
BSE: ASTALLTD · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Astal Laboratories Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Astral Limited is a leading Indian manufacturer specialising in plumbing, drainage systems, adhesives, and sealants. The company has diversified its portfolio to include bathware, paints, and sanitaryware, leveraging a robust pan-India manufacturing and distribution network.
Business Model
The company generates revenue through the manufacturing and sale of building materials, primarily piping solutions and adhesive products. It operates through a widespread distribution network that serves both residential and industrial construction sectors.
Growth Outlook
Growth is driven by the expansion into new categories such as paints and sanitaryware, alongside the continued scaling of its established piping and adhesives businesses. The company aims to leverage its strong brand equity and distribution reach to capture a larger share of the Indian building materials market.
Key Risks
- Raw Material Price Volatility. Fluctuations in the prices of petrochemical derivatives like PVC and CPVC resins can significantly impact operating margins.
- Cyclicality of Real Estate. The company's performance is closely tied to the health of the Indian construction and real estate sectors.
- Intense Market Competition. The building materials sector is highly competitive, with pressure from both established players and unorganised local manufacturers.
- Integration Risk. Successful scaling of recently acquired businesses in the paints and sanitaryware segments is critical for long-term value creation.
Start your research today
Unlock AI insights, financials, peers and live data on Astal Laboratories Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹156 Cr
TTM · standalone
NET PROFIT
₹8 Cr
TTM · standalone
EPS
₹7.00
TTM · standalone
RETURN ON EQUITY
7.5%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
11.2%
TTM · standalone
P/E
9.9x
Q4 FY26 · standalone
EV/EBITDA
24.6x
Q4 FY26 · standalone
EBITDA MARGIN
8.3%
TTM · standalone
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Astal Laboratories LimitedASTALLTD | ₹308 Cr | 9.93 | 24.62 | 142.9% | 8.3% | 7.5% | 11.2% | -16.2% |
TranschemTRANSCHEM | ₹502 Cr | 75.62 | 52.99 | -100.0% | 177.7% | 8.3% | 10.6% | +600.8% |
Albert DavidALBERTDAVD | ₹501 Cr | 21.67 | 13.19 | 11.4% | 11.0% | 5.8% | 7.5% | +10.3% |
Haleos Labs LimitedHALEOSLABS | ₹457 Cr | 28.51 | 12.83 | -3.1% | 13.6% | 7.4% | 10.3% | — |
Medicamen BiotecMEDICAMEQ | ₹434 Cr | 43.00 | 19.76 | 24.7% | 11.3% | 4.1% | 6.2% | +5.9% |
Jenburkt Pharmaceuticals LimitedJENBURPH | ₹420 Cr | 12.30 | 8.20 | — | 30.0% | 16.7% | 21.5% | -15.2% |
As of Q4 FY26
Financials
Astal Laboratories Limited
BSE: ASTALLTD · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Astal Laboratories Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Astral Limited is a leading Indian manufacturer specialising in plumbing, drainage systems, adhesives, and sealants. The company has diversified its portfolio to include bathware, paints, and sanitaryware, leveraging a robust pan-India manufacturing and distribution network.
Business Model
The company generates revenue through the manufacturing and sale of building materials, primarily piping solutions and adhesive products. It operates through a widespread distribution network that serves both residential and industrial construction sectors.
Growth Outlook
Growth is driven by the expansion into new categories such as paints and sanitaryware, alongside the continued scaling of its established piping and adhesives businesses. The company aims to leverage its strong brand equity and distribution reach to capture a larger share of the Indian building materials market.
Key Risks
- Raw Material Price Volatility. Fluctuations in the prices of petrochemical derivatives like PVC and CPVC resins can significantly impact operating margins.
- Cyclicality of Real Estate. The company's performance is closely tied to the health of the Indian construction and real estate sectors.
- Intense Market Competition. The building materials sector is highly competitive, with pressure from both established players and unorganised local manufacturers.
- Integration Risk. Successful scaling of recently acquired businesses in the paints and sanitaryware segments is critical for long-term value creation.
Start your research today
Unlock AI insights, financials, peers and live data on Astal Laboratories Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹156 Cr
TTM · standalone
NET PROFIT
₹8 Cr
TTM · standalone
EPS
₹7.00
TTM · standalone
RETURN ON EQUITY
7.5%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
11.2%
TTM · standalone
P/E
9.9x
Q4 FY26 · standalone
EV/EBITDA
24.6x
Q4 FY26 · standalone
EBITDA MARGIN
8.3%
TTM · standalone
Peers · Pharmaceuticals
As of Q4 FY26